Effect of chronic infusion of epoprostenol on echocardiographic right ventricular myocardial performance index and its relation to clinical outcome in patients with primary pulmonary hypertension

This publication has 10 references indexed in Scilit:

• Continuous Intravenous Epoprostenol for Pulmonary Hypertension Due to the Scleroderma Spectrum of Disease
  Annals of Internal Medicine, 2000
• Nongeometric quantitative assessment of right and left ventricular function: Myocardial performance index in normal children and patients with Ebstein anomaly☆☆☆★
  Journal of the American Society of Echocardiography, 1998
• Reduction in Pulmonary Vascular Resistance with Long-Term Epoprostenol (Prostacyclin) Therapy in Primary Pulmonary Hypertension
  New England Journal of Medicine, 1998
• Effects of Long-term Infusion of Prostacyclin (Epoprostenol) on Echocardiographic Measures of Right Ventricular Structure and Function in Primary Pulmonary Hypertension
  Circulation, 1997
• Doppler echocardiographic index for assessment of global right ventricular function
  Published by Elsevier ,1996
• A Comparison of Continuous Intravenous Epoprostenol (Prostacyclin) with Conventional Therapy for Primary Pulmonary Hypertension
  New England Journal of Medicine, 1996
• Pharmacodynamic profile of prostacyclin
  The American Journal of Cardiology, 1995
• Survival in Patients with Primary Pulmonary Hypertension
  Annals of Internal Medicine, 1991
• Primary Pulmonary Hypertension
  Annals of Internal Medicine, 1987
• Primary pulmonary hypertension: natural history and the importance of thrombosis.
  Circulation, 1984